{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:12:08Z","timestamp":1780701128176,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.esmoop.2022.100551","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T23:25:55Z","timestamp":1659396355000},"page":"100551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["External control cohorts for the single-arm LIBRETTO-001 trial of selpercatinib in RET+ non-small-cell lung cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"C.","family":"Rolfo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-H.","family":"Jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Kiiskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2022.100551_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101911","article-title":"RET fusions in solid tumors","volume":"81","author":"Li","year":"2019","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100551_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2005653","article-title":"Efficacy of selpercatinib in RET fusion\u2013positive non\u2013small-cell lung cancer","volume":"383","author":"Drilon","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.esmoop.2022.100551_bib3","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1200\/JCO.2021.39.15_suppl.9065","article-title":"Updated overall efficacy and safety of selpercatinib in patients (pts) with RET fusion+ non-small cell lung cancer (NSCLC)","volume":"39","author":"Besse","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100551_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cllc.2017.04.011","article-title":"Systematic review of brain metastases in patients with non\u2013small-cell lung cancer in the United States, European Union, and Japan","volume":"18","author":"Fenske","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.esmoop.2022.100551_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.lungcan.2020.11.029","article-title":"The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: a pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients","volume":"152","author":"Jiang","year":"2020","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100551_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcsm.12253","article-title":"Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer","volume":"9","author":"Mytelka","year":"2018","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.esmoop.2022.100551_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/9781119536604.ch25","article-title":"Assessing risk of bias in a non-randomized study","author":"Sterne","year":"2019","journal-title":"Cochrane Handbook Syst Rev Interv"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100551_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0974-1208.82352","article-title":"An overview of randomization techniques: an unbiased assessment of outcome in clinical research","volume":"4","author":"Suresh","year":"2011","journal-title":"J\u00a0Hum Reprod Sci"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100551_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07714-3","article-title":"Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States","volume":"21","author":"Hess","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.esmoop.2022.100551_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/pan\/mpr025","article-title":"Entropy balancing for causal effects: a multivariate reweighting method to produce balanced samples in observational studies","volume":"20","author":"Hainmueller","year":"2012","journal-title":"Polit Anal"},{"key":"10.1016\/j.esmoop.2022.100551_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/1475-6773.13669","article-title":"Validation analysis of a composite real-world mortality endpoint for patients with cancer in the United States","volume":"56","author":"Zhang","year":"2021","journal-title":"Health Serv Res"},{"issue":"22","key":"10.1016\/j.esmoop.2022.100551_bib12","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non\u2013small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9944","key":"10.1016\/j.esmoop.2022.100551_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(14)60845-X","article-title":"Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial","volume":"384","author":"Garon","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.esmoop.2022.100551_bib14","series-title":"The use of observational data to inform estimates of treatment effectiveness in technology appraisal: methods for comparative individual patient data","author":"Faria","year":"2015"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100551_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-015-0049-3","article-title":"Propensity score interval matching: using bootstrap confidence intervals for accommodating estimation errors of propensity scores","volume":"15","author":"Pan","year":"2015","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100551_bib16","first-page":"1","article-title":"Multivariate and propensity score matching software with automated balance optimization: the matching package for R","volume":"42","author":"Sekhon","year":"2011","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.esmoop.2022.100551_bib17","series-title":"Data Analysis Using Regression and Multilevel\/hierarchical Models","author":"Gelman","year":"2007"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100551_bib18","first-page":"1","article-title":"PSAgraphics: an R package to support propensity score analysis","volume":"29","author":"Helmreich","year":"2009","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.esmoop.2022.100551_bib20","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.2147\/OTT.S186361","article-title":"KIF5B-RET fusion gene and its correlation with clinicopathological and prognostic features in lung cancer: a meta-analysis","volume":"12","author":"Cong","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.esmoop.2022.100551_bib21","doi-asserted-by":"crossref","first-page":"v651","DOI":"10.1093\/annonc\/mdz260.103","article-title":"Comparison of real-world response rate (rwRR) to RECIST-based response rate in patients with advanced non-small cell lung cancer (aNSCLC)","volume":"30","author":"Ma","year":"2019","journal-title":"Ann Oncol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292200179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292200179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:28:41Z","timestamp":1761856121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S205970292200179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S205970292200179X"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100551","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External control cohorts for the single-arm LIBRETTO-001 trial of selpercatinib in RET+ non-small-cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100551"}}